The results from all studies indicated that lower MAD2 expression was not significantly associated with an increased risk of cancer recurrence (pooled HR = 0.65, 95% CI, 0.36–1.19; P = 0.16, Figure 3). The gene discussed is MAD2L1; the disease is cancer.